Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103275146A details a novel Lewis acid-catalyzed route for gastrodin, offering significant cost reduction in API manufacturing and enhanced supply chain reliability through stable intermediates.
Patent CN112824422B discloses a novel chiral ligand enabling high TON asymmetric hydrogenation for pharma intermediates with simplified synthesis.
Patent CN102219779A details a high-yield Irbesartan synthesis avoiding toxic tin reagents. Discover cost-effective manufacturing and supply chain advantages.
Patent CN103193753B reveals acidic ionic liquid catalysis for xanthene dione derivatives, offering high yield and recyclability for pharmaceutical intermediate supply chains.
Novel copper-catalyzed decarboxylative acylation method offers mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Patent CN103820416B reveals high-stereoselectivity ester hydrolase for chiral synthesis. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111454222B reveals a metal-free CO2 fixation route for quinazolinediones. This method offers high yields, mild conditions, and significant cost reduction potential.
Novel Pd/Ag catalyzed CO2 fixation route for high-purity polyimide monomers. Reduces waste and cost significantly for electronic chemical manufacturing.
Patent CN115611756A reveals a visible-light mediated synthesis for alpha-substituted glycine derivatives, offering a green route for high-purity agrochemical intermediates with reduced metal contamination.
Advanced patent CN110590606A details efficient asymmetric hydrogenation and enzymatic reduction for high-purity pharmaceutical intermediates, ensuring cost-effective and scalable supply chain solutions.
Patent CN110563605B reveals a novel PTC-catalyzed route for Etazocine intermediates, offering superior chiral purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN114409678A details a green three-component synthesis for thiazolopyrimidine derivatives using recyclable ionic liquids, offering high purity and simplified processing for API manufacturers.
Patent CN101481381B introduces a green aqueous method for Ciprofloxacin production using Lewis acid catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102260255B reveals a cost-effective two-step synthesis for 9,10-dimethoxy-3-isobutyl-benzo[a]quinolizidine-2-one using water media, offering significant supply chain advantages.
Patent CN1491951A reveals novel asymmetric hydrogenation and microbial routes for high-purity azepine intermediates, offering significant cost reduction in pharmaceutical manufacturing.
Discover advanced catalytic methods for pyrimidylcyclopentane intermediates. Enhance purity and reduce costs in AKT inhibitor manufacturing with our scalable solutions.
Novel semipinacol rearrangement route for high-purity chiral spiro ketones. Efficient scale-up for pharma intermediates and catalyst ligands.
Patent CN114456207B reveals a green visible light nickel catalyzed method for chiral beta-aryl ketones, offering cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN116143673B reveals a novel heterogeneous catalyst method for diphenyl sulfide. Achieves high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN104744380B reveals green ionic liquid catalysis for quinazolinones offering significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.